Akhil Chameettachal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Akhil Chameettachal has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Tahir Aziz Rizvi
Department of Microbiology and Immunology, College of Medicine & Health Sciences (CMHS), United Arab Emirates (UAE) University, Al Ain, UAE
10 shared publications - Roland Marquet
Université de Strasbourg, CNRS, Architecture et Réactivité de l'ARN, UPR 9002, Strasbourg, France
8 shared publications - Farah Mustafa
Department of Biochemistry & Molecular Biology, College of Medicine & Health Sciences (CMHS), United Arab Emirates (UAE) University, Al Ain, UAE
6 shared publications Lizna Mohamed Ali
Department of Microbiology & Immunology, College of Medicine and Health Sciences (CMHS), United Arab Emirates University (UAEU), Al Ain, United Arab Emirates
5 shared publicationsValérie Vivet-Boudou
Université de Strasbourg, CNRS, Architecture et Réactivité de l'ARN, UPR 9002, Strasbourg, France
5 shared publicationsAnjana Krishnan
Department of Microbiology and Immunology, College of Medicine and Health Sciences (CMHS), United Arab Emirates University (UAEU), Al Ain, United Arab Emirates
4 shared publications
Latest Publications
- Open Access
Development of a Complementation Assay to Monitor Pan-Coronavirus 3C-like Protease Activity
Coronaviruses pose a global pandemic threat, making development of a pan-coronavirus inhibitor crucial for preparedness and containment in the event of a new coronavirus outbreak. The 3C-like protease (3CLpro) is a key target for antiviral development, as it is essential for viral replication and conserved across human coronaviruses. We previously developed an assay to monitor SARS-CoV-2 3CLpro activity in cells. This assay uses a single vector that coexpresses the 3CLpro enzyme and the reporter, which consists of two luciferase fragments linked by a 3CLpro cleavage site. Cleavage of this site by 3CLpro decreases luciferase activity, whereas inhibition of 3CLpro increases the luciferase activity. Here, we adapted this assay to examine 3CLpro activity from six other human coronaviruses: SARS-CoV, MERS-CoV, HCoV-NL63, HCoV-229E, HCoV-OC43, and HCoV-HKU1. We further determined the effects of different cleavage sites to improve the signal-to-background ratio. The Nsp4-Nsp5 site and super-active substrate (SAS) resulted in the largest dynamic range for most coronaviruses in our assay. Using the broad-spectrum 3CLpro inhibitor GC376, we observed increased reporter activity, indicating the assay’s efficacy for identifying inhibitors across multiple coronaviruses. The adaptation and improvement of the assay can facilitate the development of inhibitors against 3CLpro from multiple or novel coronaviruses.
Open AccessDevelopment of a Complementation Assay to Monitor Pan-Coronavirus 3C-like Protease Activity
Coronaviruses pose a global pandemic threat, making development of a pan-coronavirus inhibitor crucial for preparedness and containment in the event of a new coronavirus outbreak. The 3C-like protease (3CLpro) is a key target for antiviral development, as it is essential for viral replication and conserved across human coronaviruses. We previously developed an assay to monitor SARS-CoV-2 3CLpro activity in cells. This assay uses a single vector that coexpresses the 3CLpro enzyme and the reporter, which consists of two luciferase fragments linked by a 3CLpro cleavage site. Cleavage of this site by 3CLpro decreases luciferase activity, whereas inhibition of 3CLpro increases the luciferase activity. Here, we adapted this assay to examine 3CLpro activity from six other human coronaviruses: SARS-CoV, MERS-CoV, HCoV-NL63, HCoV-229E, HCoV-OC43, and HCoV-HKU1. We further determined the effects of different cleavage sites to improve the signal-to-background ratio. The Nsp4-Nsp5 site and super-active substrate (SAS) resulted in the largest dynamic range for most coronaviruses in our assay. Using the broad-spectrum 3CLpro inhibitor GC376, we observed increased reporter activity, indicating the assay’s efficacy for identifying inhibitors across multiple coronaviruses. The adaptation and improvement of the assay can facilitate the development of inhibitors against 3CLpro from multiple or novel coronaviruses.
- Open Access
- 17 June 2025
- Published by American Society for Microbiology in Journal of Virology
- Vol. 99 (6) , e0015925
How to recover from a bad start: adaptation of HIV-1 transcription start site mutants during serial passaging in culture
HIV-1 uses neighboring sequences as transcription start sites and generates multiple unspliced transcripts, including two major transcripts with three guanosines (3G) or one guanosine (1G) at the 5′ end. Although only differing by 2-nt, 3G RNA and 1G RNA are functionally distinct. We have previously generated two mutants: the TTG virus mainly expresses 1G RNA, whereas the plusAC virus predominantly expresses 3G RNA. Both mutant viruses are replication-competent but exhibit fitness defects. Here, we passaged the plusAC virus in T cells and characterized the changes near the transcription start sites. We observed the rapid loss of the plusAC virus genotype and the emergence of multiple revertants. All major revertants that dominated the cultures had a 1- to 3-nt deletion that compensated for the dinucleotide insertion in the plusAC virus. These major revertants express more than one major transcript, preferentially package 1G RNA, and have improved replication kinetics compared with the plusAC virus. Most major revertants likely arose through errors during reverse transcription, including misalignments during minus-strand DNA transfer, nucleotide deletion in a homopolymer run, or deletion of a short direct repeat. Additionally, we have determined that a T-to-G substitution near transcription start sites occurs at ~5% per replication cycle by copying the guanosine cap. Converting a base to guanosine through cap copying has been observed in multiple positions, but always directly upstream of a major transcription start site. Taken together, our findings demonstrate the selection pressure for expressing functionally distinct unspliced RNA species to optimize replication fitness. IMPORTANCE: HIV-1 unspliced RNA serves as the mRNA to translate Gag/Gag-Pol polyproteins and as the virion genome. HIV-1 produces two major RNA species: 1G RNA is preferentially packaged and 3G RNA is favorably translated, although each transcript can perform both functions. We have previously generated a replication-competent mutant virus that mainly expresses 3G RNA and observed that this mutant has replication fitness defects. We found that the mutant virus improved its replication kinetics after passaging, indicating adaptation. Our analyses showed that, through mutations occurring during DNA synthesis, multiple revertants arose rapidly to replace the input mutant virus. The major revertants regained the ability to generate more than one major transcript and preferentially package 1G RNA. These results highlight the importance of expressing HIV-1 RNA species that serve distinct functions and the ability of HIV-1 to adapt through mutations in the genome.
- 17 June 2025
- Published by American Society for Microbiology in Journal of Virology
- Vol. 99 (6) , e0015925
Open AccessHow to recover from a bad start: adaptation of HIV-1 transcription start site mutants during serial passaging in culture
HIV-1 uses neighboring sequences as transcription start sites and generates multiple unspliced transcripts, including two major transcripts with three guanosines (3G) or one guanosine (1G) at the 5′ end. Although only differing by 2-nt, 3G RNA and 1G RNA are functionally distinct. We have previously generated two mutants: the TTG virus mainly expresses 1G RNA, whereas the plusAC virus predominantly expresses 3G RNA. Both mutant viruses are replication-competent but exhibit fitness defects. Here, we passaged the plusAC virus in T cells and characterized the changes near the transcription start sites. We observed the rapid loss of the plusAC virus genotype and the emergence of multiple revertants. All major revertants that dominated the cultures had a 1- to 3-nt deletion that compensated for the dinucleotide insertion in the plusAC virus. These major revertants express more than one major transcript, preferentially package 1G RNA, and have improved replication kinetics compared with the plusAC virus. Most major revertants likely arose through errors during reverse transcription, including misalignments during minus-strand DNA transfer, nucleotide deletion in a homopolymer run, or deletion of a short direct repeat. Additionally, we have determined that a T-to-G substitution near transcription start sites occurs at ~5% per replication cycle by copying the guanosine cap. Converting a base to guanosine through cap copying has been observed in multiple positions, but always directly upstream of a major transcription start site. Taken together, our findings demonstrate the selection pressure for expressing functionally distinct unspliced RNA species to optimize replication fitness. IMPORTANCE: HIV-1 unspliced RNA serves as the mRNA to translate Gag/Gag-Pol polyproteins and as the virion genome. HIV-1 produces two major RNA species: 1G RNA is preferentially packaged and 3G RNA is favorably translated, although each transcript can perform both functions. We have previously generated a replication-competent mutant virus that mainly expresses 3G RNA and observed that this mutant has replication fitness defects. We found that the mutant virus improved its replication kinetics after passaging, indicating adaptation. Our analyses showed that, through mutations occurring during DNA synthesis, multiple revertants arose rapidly to replace the input mutant virus. The major revertants regained the ability to generate more than one major transcript and preferentially package 1G RNA. These results highlight the importance of expressing HIV-1 RNA species that serve distinct functions and the ability of HIV-1 to adapt through mutations in the genome.
- Open Access
- 3 October 2024
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 22 (10) , e3002827
MMTV RNA packaging requires an extended long-range interaction for productive Gag binding to packaging signals
The packaging of genomic RNA (gRNA) into retroviral particles relies on the specific recognition by the Gag precursor of packaging signals (Psi), which maintain a complex secondary structure through long-range interactions (LRIs). However, it remains unclear whether the binding of Gag to Psi alone is enough to promote RNA packaging and what role LRIs play in this process. Using mouse mammary tumor virus (MMTV), we investigated the effects of mutations in 4 proposed LRIs on gRNA structure and function. Our findings revealed the presence of an unsuspected extended LRI, and hSHAPE revealed that maintaining a wild-type–like Psi structure is crucial for efficient packaging. Surprisingly, filter-binding assays demonstrated that most mutants, regardless of their packaging capability, exhibited significant binding to Pr77Gag, suggesting that Gag binding to Psi is insufficient for efficient packaging. Footprinting experiments indicated that efficient RNA packaging is promoted when Pr77Gag binds to 2 specific sites within Psi, whereas binding elsewhere in Psi does not lead to efficient packaging. Taken together, our results suggest that the 3D structure of the Psi/Pr77Gag complex regulates the assembly of viral particles around gRNA, enabling effective discrimination against other viral and cellular RNAs that may also bind Gag efficiently.
- 3 October 2024
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 22 (10) , e3002827
Open AccessMMTV RNA packaging requires an extended long-range interaction for productive Gag binding to packaging signals
The packaging of genomic RNA (gRNA) into retroviral particles relies on the specific recognition by the Gag precursor of packaging signals (Psi), which maintain a complex secondary structure through long-range interactions (LRIs). However, it remains unclear whether the binding of Gag to Psi alone is enough to promote RNA packaging and what role LRIs play in this process. Using mouse mammary tumor virus (MMTV), we investigated the effects of mutations in 4 proposed LRIs on gRNA structure and function. Our findings revealed the presence of an unsuspected extended LRI, and hSHAPE revealed that maintaining a wild-type–like Psi structure is crucial for efficient packaging. Surprisingly, filter-binding assays demonstrated that most mutants, regardless of their packaging capability, exhibited significant binding to Pr77Gag, suggesting that Gag binding to Psi is insufficient for efficient packaging. Footprinting experiments indicated that efficient RNA packaging is promoted when Pr77Gag binds to 2 specific sites within Psi, whereas binding elsewhere in Psi does not lead to efficient packaging. Taken together, our results suggest that the 3D structure of the Psi/Pr77Gag complex regulates the assembly of viral particles around gRNA, enabling effective discrimination against other viral and cellular RNAs that may also bind Gag efficiently.
- Open Access
- 1 November 2023
- Published by Cold Spring Harbor Laboratory in RNA
- Vol. 30 (1) , 68-88
Identification of a putative Gag binding site critical for feline immunodeficiency virus genomic RNA packaging
The retroviral Gag precursor plays a central role in the selection and packaging of viral genomic RNA (gRNA) by binding to virus-specific packaging signal(s) (psi or ψ). Previously, we mapped the feline immunodeficiency virus (FIV) ψ to two discontinuous regions within the 5′ end of the gRNA that assumes a higher order structure harboring several structural motifs. To better define the region and structural elements important for gRNA packaging, we methodically investigated these FIV ψ sequences using genetic, biochemical, and structure–function relationship approaches. Our mutational analysis revealed that the unpaired U85CUG88stretch within FIV ψ is crucial for gRNA encapsidation into nascent virions. High-throughput selective 2′ hydroxyl acylation analyzed by primer extension (hSHAPE) performed on wild type (WT) and mutant FIV ψ sequences, with substitutions in the U85CUG88stretch, revealed that these mutations had limited structural impact and maintained nucleotides 80–92 unpaired, as in the WT structure. Since these mutations dramatically affected packaging, our data suggest that the single-stranded U85CUG88sequence is important during FIV RNA packaging. Filter-binding assays performed using purified FIV Pr50Gagon WT and mutant U85CUG88ψ RNAs led to reduced levels of Pr50Gagbinding to mutant U85CUG88ψ RNAs, indicating that the U85CUG88stretch is crucial for ψ RNA–Pr50Gaginteractions. Delineating sequences important for FIV gRNA encapsidation should enhance our understanding of both gRNA packaging and virion assembly, making them potential targets for novel retroviral therapeutic interventions, as well as the development of FIV-based vectors for human gene therapy.
- 1 November 2023
- Published by Cold Spring Harbor Laboratory in RNA
- Vol. 30 (1) , 68-88
Open AccessIdentification of a putative Gag binding site critical for feline immunodeficiency virus genomic RNA packaging
The retroviral Gag precursor plays a central role in the selection and packaging of viral genomic RNA (gRNA) by binding to virus-specific packaging signal(s) (psi or ψ). Previously, we mapped the feline immunodeficiency virus (FIV) ψ to two discontinuous regions within the 5′ end of the gRNA that assumes a higher order structure harboring several structural motifs. To better define the region and structural elements important for gRNA packaging, we methodically investigated these FIV ψ sequences using genetic, biochemical, and structure–function relationship approaches. Our mutational analysis revealed that the unpaired U85CUG88stretch within FIV ψ is crucial for gRNA encapsidation into nascent virions. High-throughput selective 2′ hydroxyl acylation analyzed by primer extension (hSHAPE) performed on wild type (WT) and mutant FIV ψ sequences, with substitutions in the U85CUG88stretch, revealed that these mutations had limited structural impact and maintained nucleotides 80–92 unpaired, as in the WT structure. Since these mutations dramatically affected packaging, our data suggest that the single-stranded U85CUG88sequence is important during FIV RNA packaging. Filter-binding assays performed using purified FIV Pr50Gagon WT and mutant U85CUG88ψ RNAs led to reduced levels of Pr50Gagbinding to mutant U85CUG88ψ RNAs, indicating that the U85CUG88stretch is crucial for ψ RNA–Pr50Gaginteractions. Delineating sequences important for FIV gRNA encapsidation should enhance our understanding of both gRNA packaging and virion assembly, making them potential targets for novel retroviral therapeutic interventions, as well as the development of FIV-based vectors for human gene therapy.
- Open Access
- 16 December 2022
- Published by Elsevier in Journal of Molecular Biology
- Vol. 435 (3) , 167924
Understanding Retroviral Life Cycle and its Genomic RNA Packaging
- 16 December 2022
- Published by Elsevier in Journal of Molecular Biology
- Vol. 435 (3) , 167924
Open AccessUnderstanding Retroviral Life Cycle and its Genomic RNA Packaging
- Open Access
- 1 November 2021
- Published by Elsevier in Journal of Molecular Biology
- Vol. 433 (23) , 167293
A Stretch of Unpaired Purines in the Leader Region of Simian Immunodeficiency Virus (SIV) Genomic RNA is Critical for its Packaging into Virions
- 1 November 2021
- Published by Elsevier in Journal of Molecular Biology
- Vol. 433 (23) , 167293
Open AccessA Stretch of Unpaired Purines in the Leader Region of Simian Immunodeficiency Virus (SIV) Genomic RNA is Critical for its Packaging into Virions
- Open Access
- 1 May 2021
- Published by Elsevier in Journal of Molecular Biology
- Vol. 433 (10) , 166923
Identification of Pr78Gag Binding Sites on the Mason-Pfizer Monkey Virus Genomic RNA Packaging Determinants
- 1 May 2021
- Published by Elsevier in Journal of Molecular Biology
- Vol. 433 (10) , 166923
Open AccessIdentification of Pr78Gag Binding Sites on the Mason-Pfizer Monkey Virus Genomic RNA Packaging Determinants
- Open Access
- 9 April 2021
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 49 (8) , 4668-4688
A purine loop and the primer binding site are critical for the selective encapsidation of mouse mammary tumor virus genomic RNA by Pr77Gag
Retroviral RNA genome (gRNA) harbors cis-acting sequences that facilitate its specific packaging from a pool of other viral and cellular RNAs by binding with high-affinity to the viral Gag protein during virus assembly. However, the molecular intricacies involved during selective gRNA packaging are poorly understood. Binding and footprinting assays on mouse mammary tumor virus (MMTV) gRNA with purified Pr77Gag along with in cell gRNA packaging study identified two Pr77Gag binding sites constituting critical, non-redundant packaging signals. These included: a purine loop in a bifurcated stem-loop containing the gRNA dimerization initiation site, and the primer binding site (PBS). Despite these sites being present on both unspliced and spliced RNAs, Pr77Gag specifically bound to unspliced RNA, since only that could adopt the native bifurcated stem–loop structure containing looped purines. These results map minimum structural elements required to initiate MMTV gRNA packaging, distinguishing features that are conserved amongst divergent retroviruses from those perhaps unique to MMTV. Unlike purine-rich motifs frequently associated with packaging signals, direct involvement of PBS in gRNA packaging has not been documented in retroviruses. These results enhance our understanding of retroviral gRNA packaging/assembly, making it not only a target for novel therapeutic interventions, but also development of safer gene therapy vectors.
- 9 April 2021
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 49 (8) , 4668-4688
Open AccessA purine loop and the primer binding site are critical for the selective encapsidation of mouse mammary tumor virus genomic RNA by Pr77Gag
Retroviral RNA genome (gRNA) harbors cis-acting sequences that facilitate its specific packaging from a pool of other viral and cellular RNAs by binding with high-affinity to the viral Gag protein during virus assembly. However, the molecular intricacies involved during selective gRNA packaging are poorly understood. Binding and footprinting assays on mouse mammary tumor virus (MMTV) gRNA with purified Pr77Gag along with in cell gRNA packaging study identified two Pr77Gag binding sites constituting critical, non-redundant packaging signals. These included: a purine loop in a bifurcated stem-loop containing the gRNA dimerization initiation site, and the primer binding site (PBS). Despite these sites being present on both unspliced and spliced RNAs, Pr77Gag specifically bound to unspliced RNA, since only that could adopt the native bifurcated stem–loop structure containing looped purines. These results map minimum structural elements required to initiate MMTV gRNA packaging, distinguishing features that are conserved amongst divergent retroviruses from those perhaps unique to MMTV. Unlike purine-rich motifs frequently associated with packaging signals, direct involvement of PBS in gRNA packaging has not been documented in retroviruses. These results enhance our understanding of retroviral gRNA packaging/assembly, making it not only a target for novel therapeutic interventions, but also development of safer gene therapy vectors.
- Open Access
- 5 November 2020
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 11
Role of Purine-Rich Regions in Mason-Pfizer Monkey Virus (MPMV) Genomic RNA Packaging and Propagation
A distinguishing feature of the Mason-Pfizer monkey virus (MPMV) packaging signal RNA secondary structure is a single-stranded purine-rich sequence (ssPurines) in close vicinity to a palindromic stem loop (Pal SL) that functions as MPMV dimerization initiation site (DIS). However, unlike other retroviruses, MPMV contains a partially base-paired repeat sequence of ssPurines (bpPurines) in the adjacent region. Both purine-rich sequences have earlier been proposed to act as potentially redundant Gag binding sites to initiate the process of MPMV genomic RNA (gRNA) packaging. The objective of this study was to investigate the biological significance of ssPurines and bpPurines in MPMV gRNA packaging by systematic mutational and biochemical probing analyses. Deletion of either ssPurines or bpPurines individually had no significant effect on MPMV gRNA packaging, but it was severely compromised when both sequences were deleted simultaneously. Selective 2′ hydroxyl acylation analyzed by primer extension (SHAPE) analysis of the mutant RNAs revealed only mild effects on structure by deletion of either ssPurines or bpPurines, while the structure was dramatically affected by the two simultaneous deletions. This suggests that ssPurines and bpPurines play a redundant role in MPMV gRNA packaging, probably as Gag binding sites to facilitate gRNA capture and encapsidation. Interestingly, the deletion of bpPurines revealed an additional severe defect on RNA propagation that was independent of the presence or absence of ssPurines or the gRNA structure of the region. These findings further suggest that the bpPurines play an additional role in the early steps of MPMV replication cycle that is yet to be identified.
- 5 November 2020
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 11
Open AccessRole of Purine-Rich Regions in Mason-Pfizer Monkey Virus (MPMV) Genomic RNA Packaging and Propagation
A distinguishing feature of the Mason-Pfizer monkey virus (MPMV) packaging signal RNA secondary structure is a single-stranded purine-rich sequence (ssPurines) in close vicinity to a palindromic stem loop (Pal SL) that functions as MPMV dimerization initiation site (DIS). However, unlike other retroviruses, MPMV contains a partially base-paired repeat sequence of ssPurines (bpPurines) in the adjacent region. Both purine-rich sequences have earlier been proposed to act as potentially redundant Gag binding sites to initiate the process of MPMV genomic RNA (gRNA) packaging. The objective of this study was to investigate the biological significance of ssPurines and bpPurines in MPMV gRNA packaging by systematic mutational and biochemical probing analyses. Deletion of either ssPurines or bpPurines individually had no significant effect on MPMV gRNA packaging, but it was severely compromised when both sequences were deleted simultaneously. Selective 2′ hydroxyl acylation analyzed by primer extension (SHAPE) analysis of the mutant RNAs revealed only mild effects on structure by deletion of either ssPurines or bpPurines, while the structure was dramatically affected by the two simultaneous deletions. This suggests that ssPurines and bpPurines play a redundant role in MPMV gRNA packaging, probably as Gag binding sites to facilitate gRNA capture and encapsidation. Interestingly, the deletion of bpPurines revealed an additional severe defect on RNA propagation that was independent of the presence or absence of ssPurines or the gRNA structure of the region. These findings further suggest that the bpPurines play an additional role in the early steps of MPMV replication cycle that is yet to be identified.
- Open Access
Purification and Functional Characterization of a Biologically Active Full-Length Feline Immunodeficiency Virus (FIV) Pr50Gag
The feline immunodeficiency virus (FIV) full-length Pr50Gag precursor is a key player in the assembly of new viral particles. It is also a critical component of the efficient selection and packaging of two copies of genomic RNA (gRNA) into the newly formed virus particles from a wide pool of cellular and spliced viral RNA. To understand the molecular mechanisms involved during FIV gRNA packaging, we expressed the His6-tagged and untagged recombinant FIV Pr50Gag protein both in eukaryotic and prokaryotic cells. The recombinant Pr50Gag-His6-tag fusion protein was purified from soluble fractions of prokaryotic cultures using immobilized metal affinity chromatography (IMAC). This purified protein was able to assemble in vitro into virus-like particles (VLPs), indicating that it preserved its ability to oligomerize/multimerize. Furthermore, VLPs formed in eukaryotic cells by the FIV full-length Pr50Gag both in the presence and absence of His6-tag could package FIV sub-genomic RNA to similar levels, suggesting that the biological activity of the recombinant full-length Pr50Gag fusion protein was retained in the presence of His6-tag at the carboxy terminus. Successful expression and purification of a biologically active, recombinant full-length Pr50Gag-His6-tag fusion protein will allow study of the intricate RNA-protein interactions involved during FIV gRNA encapsidation.
Open AccessPurification and Functional Characterization of a Biologically Active Full-Length Feline Immunodeficiency Virus (FIV) Pr50Gag
The feline immunodeficiency virus (FIV) full-length Pr50Gag precursor is a key player in the assembly of new viral particles. It is also a critical component of the efficient selection and packaging of two copies of genomic RNA (gRNA) into the newly formed virus particles from a wide pool of cellular and spliced viral RNA. To understand the molecular mechanisms involved during FIV gRNA packaging, we expressed the His6-tagged and untagged recombinant FIV Pr50Gag protein both in eukaryotic and prokaryotic cells. The recombinant Pr50Gag-His6-tag fusion protein was purified from soluble fractions of prokaryotic cultures using immobilized metal affinity chromatography (IMAC). This purified protein was able to assemble in vitro into virus-like particles (VLPs), indicating that it preserved its ability to oligomerize/multimerize. Furthermore, VLPs formed in eukaryotic cells by the FIV full-length Pr50Gag both in the presence and absence of His6-tag could package FIV sub-genomic RNA to similar levels, suggesting that the biological activity of the recombinant full-length Pr50Gag fusion protein was retained in the presence of His6-tag at the carboxy terminus. Successful expression and purification of a biologically active, recombinant full-length Pr50Gag-His6-tag fusion protein will allow study of the intricate RNA-protein interactions involved during FIV gRNA encapsidation.